Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model
about
Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost-effectiveness Analysis.Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control.Cost-effectiveness of Intensive Blood Pressure Management.Potential U.S. Population Impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline.Potential U.S. Population Impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline.
P2860
Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparative Cost-Effectiveness ...... ovascular Disease Policy Model
@en
Comparative Cost-Effectiveness ...... vascular Disease Policy Model.
@nl
type
label
Comparative Cost-Effectiveness ...... ovascular Disease Policy Model
@en
Comparative Cost-Effectiveness ...... vascular Disease Policy Model.
@nl
prefLabel
Comparative Cost-Effectiveness ...... ovascular Disease Policy Model
@en
Comparative Cost-Effectiveness ...... vascular Disease Policy Model.
@nl
P2093
P2860
P1433
P1476
Comparative Cost-Effectiveness ...... ovascular Disease Policy Model
@en
P2093
Andrew E Moran
Anthony Rodgers
Chen Huang
Ciaran N Kohli-Lynch
Keane Y Tzong
Lee Goldman
Nathalie Moise
Pamela G Coxson
P2860
P356
10.1161/HYPERTENSIONAHA.115.06814
P407
P577
2016-05-15T00:00:00Z